ey0019.4-3 | Important for clinical practice | ESPEYB19
C Jagodzinski , S Mueller , R Kluck , K Froede , L Pavicic , J Gellermann , D Mueller , U Querfeld , D Haffner , M Zivicnjak
ey0019.5-10 | Translational highlights | ESPEYB19
Z Cheng , K O'Brien , J Howe , C Sullivan , D Schrier , A Lynch , S Jungles , Y Sabbagh , D Thompson
ey0017.7-7 | Basic Science | ESPEYB17
F Ruiz-Pino , D Miceli , D Franssen , MJ Vazquez , A Farinetti , JM Castellano , G Panzica , M Tena-Sempere
ey0017.9-12 | Childhood Cancer, Radiation Therapy and Thyroid Disease | ESPEYB17
J Hess , K Schafernak , D Newbern , T Vern-Gross , J Foote , D Van Tassel , R Jamshidi , A Walsh
ey0015.2-8 | MEHMO syndrome is a novel X-linked retardation syndrome associated with neonatal hypoglycaemia, hypopituitarism and early onset diabetes mellitus | ESPEYB15
J Stanik , M Skopkova , D Stanikova , K Brennerova , L Barak , L Ticha , J Hornova , I Klimes , D Gasperikova
ey0015.2-10 | MEHMO syndrome is a novel X-linked retardation syndrome associated with neonatal hypoglycaemia, hypopituitarism and early onset diabetes mellitus | ESPEYB15
S Moortgat , J Désir , V Benoit , S Boulanger , H Pendeville , MC Nassogne , D Lederer , I Maystadt
ey0015.14-5 | Gut flora is shaped by the environment | ESPEYB15
D Rothschild , O Weissbrod , E Barkan , A Kurilshikov , T Korem , D Zeevi , PI Costea , A Godneva , IN Kalka , N Bar
ey0020.4-11 | Psychological Effects of Hormone Treatments | ESPEYB20
D Chen , J Berona , YM Chan , D Ehrensaft , R Garofalo , MA Hidalgo , SM Rosenthal , AC Tishelman , J Olson-Kennedy
ey0020.10-13 | Dyslipidemia | ESPEYB20
CS Dhanasekara , D Ancona , L Cortes , A Hu , AH Rimu , C Robohm-Leavitt , D Payne , SM Wakefield , AM Mastergeorge , CN Kahathuduwa
ey0021.8-6 | Important for Clinical Practice | ESPEYB21
A Galderisi , D Kariyawasam , A Stoupa , AN Quoc , G Pinto , M Viaud , S Brabant , J Beltrand , M Polak , D Samara-Boustani